Selective Neuromodulator Effects on Mouse Behavior
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Wellcome Centre for Integrative Neuroimaging
Variable analysis
- Tolcapone (30mg/kg)
- GBR-12909 dihydrochloride (6mg/kg)
- D-amphetamine (4mg/kg)
- Atomoxetine (1mg/kg)
- Not explicitly mentioned
- Vehicle control (20% hydroxypropyl-beta-cyclodextrin in 0.9% saline)
- Doses of drugs chosen to alter behavior without causing motor stereotypies (see Supplementary Information)
- Positive control: None mentioned
- Negative control: Vehicle control (20% hydroxypropyl-beta-cyclodextrin in 0.9% saline)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!